The Conversation (0)
G1 Therapeutics earned approximately $108.6 million thanks to its now closed initial public offering.
G1 Therapeutics (NASDAQ:GTHX) earned approximately $108.6 million thanks to its now closed initial public offering.
As quoted in the press release:
The shares began trading on The NASDAQ Global Select Market on May 17, 2017 under the ticker symbol “GTHX.”
J.P. Morgan Securities LLC and Cowen and Company, LLC acted as joint book-running managers for the offering. Needham & Company, LLC and Wedbush PacGrow acted as co-managers for the offering.
Click here to read the full press release.
Source: globenewswire.com
